Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?

Literature DB >> 2069841

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?

J A Child.

Abstract

Entities: Disease

Mesh：

Substances：
Biomarkers, Tumor

Year: 1991 PMID： 2069841 PMCID： PMC1972544 DOI： 10.1038/bjc.1991.186

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

39 in total

1. Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas, and the leukemias.

Authors: H R BIERMAN; B R HILL; L REINHARDT; E EMORY
Journal: Cancer Res Date: 1957-08 Impact factor: 12.701

2. Report of the Committee on Hodgkin's Disease Staging Classification.

Authors: P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal: Cancer Res Date: 1971-11 Impact factor: 12.701

3. Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients.

Authors: J A Child; B Spati; S Illingworth; D Barnard; S Corbett; A V Simmons; J Stone; T S Worthy; E H Cooper
Journal: Cancer Date: 1980-01-15 Impact factor: 6.860

4. Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma.

Authors: F Cabanillas; J S Burke; T L Smith; T E Moon; J J Butler; V Rodriguez
Journal: Arch Intern Med Date: 1978-03

5. 3H-thymidine uptake in chronic lymphocytic leukaemia cells.

Authors: B Simonsson; K Nilsson
Journal: Scand J Haematol Date: 1980-02

6. Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study.

Authors: B Späti; J A Child; S M Kerruish; E H Cooper
Journal: Acta Haematol Date: 1980 Impact factor: 2.195

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?

1. Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas, and the leukemias.

2. Report of the Committee on Hodgkin's Disease Staging Classification.

3. Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients.

4. Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma.

5. 3H-thymidine uptake in chronic lymphocytic leukaemia cells.

6. Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study.

7. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia.

8. Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas.

9. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.

10. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma.

1. Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.